FDA Adverse Event Injury Summary report: N

CLICKFINE 32GX4MM DONGBAO 7ER

MDR report key: 20211206 · Received September 13, 2024

Report

Report Number
3002806818-2024-00023
Event Type
Injury
Date Received
September 13, 2024
Date of Event
July 16, 2024
Report Date
September 13, 2024
Manufacturer
YPSOMED AG
Product Code
FMI
PMA / PMN Number
K171984
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

DURING AN INSULIN INJECTION, THE PATIENT'S PUNCTURE SITE APPEARED HARD, RED, AND SWOLLEN. THE PATIENT EXPRESSED EMOTIONAL DISTRESS AND FELT PHYSICAL PAIN AND HEAT IN THE PUNCTURE SITE, AMONG OTHER ADVERSE REACTIONS. A SURGICAL CONSULTATION WAS REQUESTED. THE DOCTOR USED TDP IRRADIATION AND LOCAL ANTI-INFECTION TREATMENT TO ADDRESS THE ISSUE. A REVIEW FOR ANY INTERNAL DEVIATIONS DURING PRODUCTION SHOWED NO ABNORMALITIES OR DEVIATIONS FROM THE VALIDATED MANUFACTURING PROCESS. IN-PROCESS CONTROL FOR THE NEEDLE TIP TO THE CANNULA IS 100% COMPLETED BEFORE THE INNER PROTECTIVE CAP IS FITTED. A REVIEW OF BIOBURDEN, ENDOTOXIN LAL, AND IRRADIATION CERT SHOWED NO ANOMALIES. BIOCOMPATIBILITY TESTING COMPLETED UNDER ISO 10993 SERIES PASSED. NO DEVICE PROBLEM COULD BE FOUND.

Description of Event or Problem · 0

AT 13:54PM ON (B)(6) 2024, WHEN USING THE INJECTION PEN NEEDLE TO INJECT INSULIN FOR THE PATIENT'S TREATMENT; AT 14:00PM, THE PATIENT'S PUNCTURE SITE APPEARED TO BE RED, SWOLLEN, HOT AND PAINFUL, AND OTHER ADVERSE REACTIONS, THEN STOPPED TO USE THIS NEEDLE; AT 14:05 , IT WAS FOUND THAT THE PATIENT'S INJECTION SITE APPEARED TO BE HARD AND RED SWOLLEN, THEN IMMEDIATELY ASKED FOR A SURGICAL CONSULTATION. AFTER THE CONSULTATION, THE DOCTOR USED TDP IRRADIATION, LOCAL ANTI-INFECTION TREATMENT, WHICH LEADED TO THE PATIENT'S PHYSICAL AND MENTAL DAMAGE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1106555 CLICKFINE 32GX4MM DONGBAO 7ER PEN NEEDLE FMI YPSOMED AG CLICKFINE 32GX4MM DONGBAO 7ER 231121-02

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention